27.92 USD
↘ 0.10 (0.34%)LIVE (AS OF 01:15 PM EST)
Zenas BioPharma, Inc. Common Stock (ZBIO) trades at $27.92 per share. The stock presents a mixed profile: our models indicate a Strong Buy for technical indicators, while underlying fundamentals flash a Sell. Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. Furthermore, ZBIO is currently richly valued, trading at a premium to sector peers across key valuation metrics.
Technical & fundamental data as of Nov 13, 2026.